ZENTALIS PHARMACEUTICALS INC (ZNTL) Institutional Ownership and Insiders Activity
ZENTALIS PHARMACEUTICALS INC (ZNTL) is widely held by institutional investors, with 117 firms reporting positions valued at approximately $227.45M based on SEC Form 13F filings for the quarter ended June 30, 2026.
5Am Venture Management, Llc is the largest disclosed holder, reporting approximately $19.15M in ZNTL holdings in its latest filing.
Recent insider activity includes 2 tracked Form 4 transactions over the last three months, reflecting ongoing executive and director trading activity.
Institutional Holders
117
Total Reported Value
$227.45M
Largest Holder
5Am Venture Management, Llc
Largest Position
$19.15M
Insider Transactions (90d)
2
Latest Filing Quarter
Q2 2026
New Institutional Positions
35
Funds Exiting Positions
23
Top Institutional Owners
View allInvestorReported Balance
- 5Am Venture Management, Llc$19.15M
- Blackrock, Inc.$18.20M
- Squadron Capital Management Llc$17.95M
- Two Sigma Investments, Lp$14.67M
- Vanguard Capital Management Llc$13.75M
Related ZNTL Institutional Insights:
- ZNTL 13F Institutional Holders
- ZNTL Superinvestors
- ZNTL Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- ZNTL Insider Trading & SEC Form 4 Activity
- ZNTL Articles
- Top Institutional Investor Stock Rankings